"id","description","instanceType","name","uuid:ID","label","text"
"Objective_1","Main objective","Objective","OBJ1","d3c6cedf-934e-4e71-9299-b7e9b27b4446","","To determine if there is a statistically significant relationship (overall Type 1 erroralpha=0.05) between the change in both the ADAS-Cog (11) and CIBIC+ scores, and drug dose (0, 50 cm2 [54 mg], and 75 cm2 [81 mg])."
"Objective_2","Safety","Objective","OBJ2","1bc03fd1-5351-4944-a2b2-027f891b12d8","","To document the safety profile of the xanomeline TTS."
"Objective_3","Behaviour","Objective","OBJ3","66740734-a56c-4216-a35e-54bea9a20789","","To assess the dose-dependent improvement in behavior. Improved scores on the Revised Neuropsychiatric Inventory (NPI-X) will indicate improvement in these
areas."
